Diagnostic value of N-terminal ProB-Type Natriuretic Peptide in Emergency Department: Analysis by subgroups


Submitted: 11 February 2013
Accepted: 11 February 2013
Published: 13 December 2012
Abstract Views: 896
PDF: 1100
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • P. Villa Medicine I, Emergency Department, Luigi Sacco Hospital, Italy.
  • A. Dolci Clinical Biochemistry Laboratory, Luigi Sacco Hospital, Italy.
  • R. Dominici Clinical Biochemistry Laboratory, Luigi Sacco Hospital, Italy.
  • M. Panteghini Department of Clinical Sciences, University of Milan, Milan, Italy.
  • C. Fundarò Medicine I, Emergency Department, Luigi Sacco Hospital, Italy.
  • S. Guzzetti Medicine I, Emergency Department, Luigi Sacco Hospital, Italy.
Objectives. Our aim was to evaluate the diagnostic impact of N-terminal pro B-type natriuretic peptide (NT-proBNP) measurement in patients presenting with acute dyspnea in Emergency Department (ED), taking into account clinical and chest x-ray results routinely obtained. Methods. This was a prospective observational study. Four hundred eighty-eight consecutive subjects evaluated for dyspnea in a metropolitan 600 beds hospital ED, entered into the final data analysis. According to a clinical and radiological score, the patients enrolled were divided in three groups: low (A-group), intermediate (B-group), and high (C-group) probability of heart failure. Results. NT-proBNP median value was 2445 ng/L (Inter Quartile Range 631-5847 ng/L), and the area under the receiver-operating characteristic curves (AUC) was 0.854 for NT-proBNP, 0.921 for clinical/radiological score and 0.936 for the two in combination (logistic model). In the B-group (intermediate) NT-proBNP test added correct diagnostic information in 126 subjects with HF and in 53 subjects without a final diagnosis of HF. In A- and C-group NT-proBNP test added correct diagnostic information in 1 patient. Conclusions. NT-proBNP did not substantially enhance diagnostic accuracy in all patients with shortness of breath in ED. However, in patients with not conclusive clinical and radiological results NT-proBNP determinations improved the percentage of correct diagnosis.

Villa, P., Dolci, A., Dominici, R., Panteghini, M., Fundarò, C., & Guzzetti, S. (2012). Diagnostic value of N-terminal ProB-Type Natriuretic Peptide in Emergency Department: Analysis by subgroups. Emergency Care Journal, 8(3), 34–38. https://doi.org/10.4081/ecj.2012.3.34

Downloads

Download data is not yet available.

Citations